Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215013 · ClinicalTrials.gov registry record · NA
Acoustic Resonance Therapy for Treating Empty Nose Syndrome
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07215013: Clinical Trial NA study, sponsored by Stanford University.
NCT07215013 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07215013, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is to determine whether Acoustic Resonance Therapy (ART), an FDA-approved treatment for standard nasal obstruction, may be helpful in mitigating the debilitating symptoms of Empty Nose Syndrome (ENS), which includes an alternative form of nasal obstruction. ART is a non-invasive treatment that uses sound vibrations to improve nasal congestion and other sinus symptoms. ART works by delivering specific frequencies of sound to the sinonasal cavities (nose and sinuses). These vibrations cause the tissues in the sinuses to resonate, which can help break up mucus and clear blockages, reduce inflammation, and improve airflow.
Interventions
- DEVICE Personalized ART
- DEVICE Non-personalized ART
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2028-07 |
| Est. Completion | 2030-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07215013
The ClinicalTrials.gov registry entry for NCT07215013 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Personalized ART is the first listed.
NCT07215013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07215013 about?
NCT07215013 is a clinical study titled "Acoustic Resonance Therapy for Treating Empty Nose Syndrome". This study is to determine whether Acoustic Resonance Therapy (ART), an FDA-approved treatment for standard nasal obstruction, may be helpful in mitigating the debilitating symptoms of Empty Nose Syndrome (ENS), which includes an alternative form of nasal obstruction. ART is a non-invasive treatment...
What is the current status of trial NCT07215013?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2028-07. Estimated completion is 2030-07.
What interventions are being tested in trial NCT07215013?
The interventions under investigation include: Personalized ART (DEVICE), Non-personalized ART (DEVICE).
Who is sponsoring clinical trial NCT07215013?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.